Canada markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0800+0.0300 (+2.86%)
At close: 04:00PM EDT
1.1200 +0.04 (+3.70%)
After hours: 06:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.0500
Open1.0500
Bid1.0600 x 100
Ask1.1300 x 100
Day's Range1.0100 - 1.1100
52 Week Range0.8500 - 2.0000
Volume41,544
Avg. Volume195,385
Market Cap28.005M
Beta (5Y Monthly)1.06
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

    EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces its operating results for the second quarter fiscal year 2024 ended March 31, 2024. Second Quarter Fiscal Year 2024 and Recent Business Updates Financial Highlights: Product revenue of $1,377,000 in Q2 202

  • GlobeNewswire

    NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14

    EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call and webcast on May 14, 2024 at 4:30 PM Eastern Time to discuss financial results for its second quarter of fiscal year 2024 ended March 31, 2024, and provide a corporate update. Conference Call

  • GlobeNewswire

    NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology

    EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces an appearance by Chief Executive Officer Dave Rosa on Bloomberg Television's Bloomberg Technology. A replay of the segment, which aired live yesterday, can be viewed at NeuroOne-Bloomberg. In conversation with